Study of acute liver failure in children
Part of Digestive system clinical trials.
This trial looks at children with sudden severe liver injury. It tests treatments for acute liver failure to understand how to help them recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be under 18 years old.
- Liver problems started suddenly within the last 8 weeks and you did not have liver disease before.
- Blood tests show serious liver damage.
- You have blood clotting issues not fixed by vitamin K: either a prothrombin time of 15 seconds or more with confusion from liver problems, or a prothrombin time of 20 seconds or more even without confusion.
- You agree to share your medical records and treatment details.
- You and your family agree to take part and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what causes acute liver failure in children in China and how well they recover. By understanding these factors, doctors hope to improve care and predict outcomes better.
This study looks at people with acute liver failure—a serious condition where the liver suddenly stops working—to understand what causes it and predict how patients will do. Researchers collect information about patients' health to identify patterns that might help doctors treat future patients better.
This trial tests whether a higher volume of plasma exchange (cleaning the blood to remove toxins) works better than the standard amount for children with acute liver failure who are not improving with usual care.
This study analyzes gene activity in patients with severe liver failure or sepsis to understand why some recover and others don't. It may lead to better treatments in the future.
This Phase 2 trial tests an injection medicine (F573) to see if it can improve people with liver injury, drug-related liver damage, or liver failure. You may be screened with blood tests, liver stiffness measurements, and possibly symptom checks.
This trial tests a new drug called AS1501 for people with acute-on-chronic liver failure (a sudden worsening of chronic liver disease). It aims to see if the drug can help improve liver function and reduce the need for a liver transplant. You may be eligible if you are in the early or middle stage of this condition and have a specific blood marker (high TRAIL level).
Hear when a new Acute Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.